Notice2022-23989
Meeting of the Tick-Borne Disease Working Group
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 4, 2022
Issuing agencies
Health and Human Services Department
Abstract
The Office of the Assistant Secretary for Health published a notice in the Federal Register on September 16, 2022, concerning a meeting of the Tick-Borne Disease Working Group (TBDWG) that was scheduled to occur on December 7, 2022. This notice is being amended to announce that the meeting has been rescheduled to November 21, 2022. This will be the final TBDWG meeting.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 213 (Friday, November 4, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 213 (Friday, November 4, 2022)]
[Notices]
[Pages 66714-66715]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-23989]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Tick-Borne Disease Working Group
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice; revision to meeting date.
-----------------------------------------------------------------------
SUMMARY: The Office of the Assistant Secretary for Health published a
notice in the Federal Register on September 16, 2022, concerning a
meeting of the Tick-Borne Disease Working Group (TBDWG) that was
scheduled to occur on December 7, 2022. This notice is being amended to
announce that the meeting has been rescheduled to November 21, 2022.
This will be the final TBDWG meeting.
DATES: The meeting date announced in the Federal Register at 87 FR 5693
on September 16, 2022 is amended. The public can view the meeting
online via webcast on November 21, 2022 from approximately 10 a.m. to
12 p.m. ET (times are tentative and subject to change). The confirmed
times and agenda items for the meeting will be posted on the TBDWG web
page at <a href="https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/index.html">https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/index.html</a> when this information becomes available.
[[Page 66715]]
FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal
Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS
Policy, Office of the Assistant Secretary for Health, Department of
Health and Human Services, Tower Building, 1101 Wootton Parkway,
Rockville, MD 20852. Email: <a href="/cdn-cgi/l/email-protection#65110c060e070a170b00010c1600041600250d0d164b020a13"><span class="__cf_email__" data-cfemail="53273a3038313c213d36373a2036322036133b3b207d343c25">[email protected]</span></a>. Phone: 202-795-
7608.
SUPPLEMENTARY INFORMATION: A link to view the webcast can be found on
the meeting website at <a href="https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/index.html">https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/index.html</a> when it becomes available. The
public will have an opportunity to present their views to the TBDWG
orally during the meeting's public comment session or by submitting a
written public comment. Comments should be pertinent to the meeting
discussion. Persons who wish to provide verbal or written public
comment should review instructions at <a href="https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/index.html">https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/index.html</a> and respond by midnight
November 13, 2022 ET. Verbal comments will be limited to three minutes
each to accommodate as many speakers as possible during the 30-minute
session. Written public comments will be accessible to the public on
the TBDWG web page prior to the meeting.
Dated: October 25, 2022.
James J. Berger,
Designated Federal Officer, Tick-Borne Disease Working Group, Office of
Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2022-23989 Filed 11-3-22; 8:45 am]
BILLING CODE 4150-28-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 4, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.